OraSure Technologies is currently navigating a critical transition period characterized by a 99.9% year-over-year revenue decline in 2026Q1 as pandemic-era demand evaporates.
Price trend, volume and key moving averages
Trailing total returns as of 11/8/2026, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC).
Check whether operating performance supports the current valuation.
Recent results and news deserve attention only when they alter the forward view.
| Quarter | EPS (Act vs Est) | Revenue (Act vs Est) |
|---|---|---|
Q3 2026Latest Aug 5, 2026 | $0.09+133.3% vs -$0.27 | $31M+5.3% vs $29M |
Q2 2026 May 6, 2026 | -$0.32-39.1% vs -$0.23 | $28M+0.8% vs $28M |
Q1 2026 Feb 25, 2026 | -$0.27-58.8% vs -$0.17 | $27M+1.0% vs $26M |
Q4 2025 Nov 5, 2025 | -$0.19-18.8% vs -$0.16 | $27M-7.0% vs $29M |
Collaboration will bring diagnostics expertise to a global, multi-stakeholder effort focused on policy, advocacy, and practical implementation Collaboration will bring diagnostics expertise to a global, multi-stakeholder effort focused on policy, advocacy, and practical implementation
BETHLEHEM, Pa., Oct. 26, 2026 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ: OSUR) announced today that it will report its third quarter 2026 financial results on Monday, November 9, 2026, after the market closes. It will hold its quarterly conference call to discuss the results beginning at 5:00 p.m. Eastern Time on that day.
OraSure Technologies, Inc. (NASDAQ: OSUR - Get Free Report) crossed above its 200-day moving average during trading on Wednesday. The stock has a 200-day moving average of $3.71 and traded as high as $3.81. OraSure Technologies shares last traded at $3.71, with a volume of 355,981 shares. Analyst Ratings Changes Several equities analysts have weighed in
Establishment Labs (NASDAQ: ESTA - Get Free Report) and OraSure Technologies (NASDAQ: OSUR - Get Free Report) are both small-cap healthcare companies, but which is the better business? We will compare the two companies based on the strength of their dividends, risk, institutional ownership, profitability, valuation, earnings and analyst recommendations. Analyst Recommendations This is a summary of
Benchmark OSUR against direct peers instead of judging its metrics in isolation.
Key metrics vs top competitors for OraSure Technologies, Inc. (OSUR)
| Company | Price | Market Cap | P/E Ratio | Rev Growth (1Y) | Net Margin | ROE | Div Yield |
|---|---|---|---|---|---|---|---|
| $3.44 | $236.84M | -4.91 | -38.1% | -43.7% | -14.73% | — | |
| $10.70 | $729.64M | -1.99 | -1.89% | -14.24% | -20.13% | — | |
| $676.04 | $53.33B | 45.20 | 10.42% | 25.36% | 71.18% | — | |
| $109.93 | $191.48B | 40.64 | 5.67% | 9.75% | 9% | 2.14% | |
| $211.88 | $58.38B | 50.76 | -10.91% | 5.66% | 3.67% | 1.96% | |
| $11.76 | $2.56B | -45.71 | -2.71% | -6.35% | -2.68% | — |
OraSure Technologies, Inc. (OSUR) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.
Verify the primary filings, follow material updates, and answer the remaining questions.
OraSure Technologies, Inc. (OSUR) SEC filings — annual & quarterly reports (10-K, 10-Q)
Aug 5, 2026·SEC
Jun 11, 2026·SEC
May 6, 2026·SEC
Get notified when OSUR posts new earnings or crosses analyst targets
Free. No account needed. Unsubscribe any time.
OraSure Technologies, Inc. (OSUR) stock FAQ — growth, dividends, profitability & financials explained
OraSure Technologies, Inc. (OSUR) reported $112.4M in revenue over the trailing twelve months. Revenue was $115.0M in fiscal year 2025. That is 67% more than the $68.7M of fiscal year 1996.
OraSure Technologies, Inc. (OSUR) revenue fell by 18.9% over the trailing twelve months, compared with the twelve months before.
No. OraSure Technologies, Inc. (OSUR) reported a net loss of $49.1M over the trailing twelve months.
OraSure Technologies, Inc. (OSUR) had a return on equity (ROE) of -14.7% over the trailing twelve months. A negative ROE means the company lost money over the period.
OraSure Technologies, Inc. (OSUR) had negative free cash flow of $48.1M over the trailing twelve months.
